Search

Background: The citizens' perspectives on health care are central to the assessment of the health care situation and to regional development. In Germany, however, strategic goals for health care delivery are planned based on population statistics and partly on regional morbidity. Saxony is a German federal state with high average age and low density of physicians which makes the population perspective on quality of health care especially intersting. No existing panel surveys cover issues related to the perceived quality of health care delivery on a regional level in Germany., Aim: We aim to conduct a longitudinal panel study of the perceived health status and perceived quality of health care of the Saxon citizens as a basis for the systematic derivation of health care goals/measures and target group-specific, regionally suitable prevention measures., Methods: With an anticipated 15% response rate, 15,000 potential participants have to be contacted to achieve a calculated sample size of about 2,250 participants. The questionnaire will be circulated every other year with the option for adaptations depending on insights of each panel wave. The study protocol was approved by the local ethics committee of the Technische Universität Dresden, Germany (ethical approval code BO-EK-320072022) and has been registered at the German Clinical Trials Register as the German WHO primary registry (study registration number DRKS00031229)., Discussion and Outlook: The results are intended to identify gaps in health care and to develop patient-centered health care goals for the region together with stakeholders in Saxon health care planning. At the same time, longitudinal data allow mapping of perceived health status and perceived health care trends., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: JS reports institutional grants for investigator-initiated research from the German GBA, the BMG, BMBF, EU, Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He also participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. JS serves the German Ministry of Health as a member of the Sachverständigenrat Gesundheit und Pflege. MK reports institutional grants for investigator-initiated research from the German GBA, the EU, BMBF and the DFG. LH reports fees from the Volkswagen Foundation and from Thieme. LR and TH report fees from the aQua-Institut. These reports are unrelated to this study. This does not alter our adherence to PLOS ONE policies on sharing data and materials., (Copyright: © 2024 Harst et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

The German Innovation Fund has funded various studies on patient safety. Their thematic spectrum, methodological quality, results and recommendations of the Innovation committee were to be systematically investigated in order to derive proposals for optimizing transfer success. As part of a scoping review, all Innovation Fund projects funded in the period 2016-02/2023 with a focus on patient safety were analyzed. Each included study document was critically reviewed by two independent persons. The 16 included projects addressed a wide range of populations, indications and interventions. The study quality was mostly good. The results ranged from feasible indicator sets and the prevention of adverse drug reactions to the optimization of error management. For seven projects, the Innovation Committee recommended forwarding the results to healthcare institutions with the request that they take note and/or examine the feasibility of implementation in standard care. Implementation, however, has not yet taken place. In order to facilitate implementation, the joint development of an implementation strategy by the recipients of the Innovation Committee's recommendations is necessary., Competing Interests: Lorenz Harst: Unabhängig von diesem Projekt hat LH von der Volkswagen Stiftung finanzielle Unterstützung für die Teilnahme an einem Scoping-Workshop zu Organisationsbezogener Versorgungsforschung erhalten. Lilly Rüthrich: Unabhängig von diesem Projekt führt LR die Aktualisierung des QISA-Bandes C6 Depression für das aQua-Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen GmbH durch. Felix Walther: FW hat keine Interessenkonflikte. Laura Keßler: LK hat keine Interessenkonflikte. Christina Lindemann: CL: ist Mitglied im Deutschen Netzwerk Versorgungsforschung und hat von diesem und der DKG Reisekosten finanziert bekommen. Martin Härter: Unabhängig von diesem Projekt hat MH institutionelle Fördermittel von DFG, BMBF, BMG, Innovationsfonds, DAK Gesundheit u. a. sowie Beratungshonorare vom IQTIG und der TK erhalten. MH ist Vorsitzender des Beirats und wissenschaftlicher Leiter beim Ärztlichen Zentrum für Qualität in der Medizin (ÄZQ) in Berlin. Erik Farin-Glattacker: Unabhängig von diesem Projekt erhielt EFG institutionelle Fördermittel für wissenschaftlich-initiierte Forschung vom BMBF, BMAS, Gemeinsamer Bundesausschuss (Innovationsfonds), Deutsche Rentenversicherung, GKV; EFG ist Mitglied des wissenschaftlichen Beirats des IQTIG. Max Geraedts: MG war Teil der Leitung des Projekts IMPRESS Unabhängig von diesem Projekt erhielt MG institutionelle Fördermittel für wissenschaftlich-initiierte Forschung vom GB-A, BMBF, HMWK, Gesundheitsamt Marburg; zudem Gutachten- bzw. Vortrags- oder Beraterhonorare des IQTIG, APS, der Universitäten Hamburg, Dresden, Witten/Herdecke; KCQ-BW, LAG-QS-NS, LAG-QS-Bayern; MG ist Mitglied des wissenschaftlichen Beirats des IQTIG. Jochen Schmitt: JS war Teil der Leitung des Projekts IMPRESS. Unabhängig von diesem Projekt erhielt JS institutionelle Fördermittel für wissenschaftlich-initiierte Forschung vom GB-A, dem BMG, BMBF, Freistaat Sachsen, Novartis, Sanofi, ALK und Pfizer. Er nahm als Berater an Advisory Board Meetings der Firmen Sanofi, Lilly und ALK teil und erhielt hierfür ein persönliches Honorar. JS ist Mitglied des Sachverständigenrat Gesundheit und Pflege am Bundesministerium für Gesundheit und Mitglied der Regierungskommission für eine moderne und bedarfsgerechte Krankenhausversorgung der Ampelkoalition., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)